EGFR and central nervous system cancer: Most causal genes underwent copy number variation (CNV) in glioma samples, with AS3MT, DNA2, and SCDF1 being predominantly heterozygous deletion, while RASA4 and EGFR were predominantly heterozygous and homozygous amplification.